SL-11047

· Progen Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SL-11047, covering 2016-06-23 to 2016-06-23. Get the full timeline:

Most recent: Clinical Trial Update: SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma [Phase 1]